Literature DB >> 24261411

Evaluation of the frequency and the association of sexual pain and chronic headaches.

Allan Gordon1, Denise Paneduro, Leah Pink, Valerie Lawler, Christine Lay.   

Abstract

BACKGROUND: Sexual pain and chronic headaches are both complex conditions with associated high disability. Little research has examined whether there is a relationship between the 2. The aim of this survey-based study was to explore the frequency of sexual pain in a population of women being treated for chronic headache. Peripheral aims included exploring the number of patients receiving treatment for sexual pain and the association between sexual pain and libido, and history of abuse.
METHODS: Patients presenting to an ambulatory chronic headache clinic were administered a short 10-item survey.
RESULTS: Forty-four percent of patients reported that they had pelvic region or genital pain brought on by sexual activity. Only half of these patients had ever discussed their pelvic pain with a health care provider, and 31% of these patients had not received treatment. Almost all patients would be interested in treatment if available. Seventy-five percent of patients indicated a change in libido.
CONCLUSION: Chronic headaches and sexual pain are both conditions that have a significant impact on patients and the health care system, and they do coexist. More research is needed to look at the relationship between these conditions in addition to epidemiology, symptomatology, evaluation, and treatments.
© 2013 American Headache Society.

Entities:  

Keywords:  chronic headache; chronic pain; pelvic pain; sexual pain

Mesh:

Year:  2013        PMID: 24261411     DOI: 10.1111/head.12271

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  1 in total

1.  Incidence and risk factors for chronic pelvic pain after hysteroscopic sterilization.

Authors:  Amanda C Yunker; Jessica M B Ritch; Erica F Robinson; Cara T Golish
Journal:  J Minim Invasive Gynecol       Date:  2014-06-19       Impact factor: 4.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.